Neurotech International Limited

ASX:NTI.AX

0.02 (AUD) • At close June 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q2
Revenue 0.114-0.0330.0020.0030.0030.4080.0480.1750.0310.0410.0360.0110.184-0.0220.0520.0480.040.1280.085
Cost of Revenue 5.6912.2320.9512.2112.0211.1510.3550.2530.1920.3250.2980.7050.9550.060.0270.1350.1230.0450.007
Gross Profit -5.577-2.265-0.949-2.208-2.018-0.742-0.308-0.077-0.161-0.284-0.262-0.695-0.771-0.0820.025-0.087-0.0830.0830.078
Gross Profit Ratio -49.04268.132-629.858-743.115-675.265-1.818-6.446-0.441-5.244-6.938-7.203-64.895-4.1923.6710.48-1.81-2.0580.6460.917
Reseach & Development Expenses 5.6913.012.2374.2452.2071.3941.1842.9030.281000.0430.0630.2360.0540.2090.0340.0280
General & Administrative Expenses 0.6940.620.5090.4430.5060.2790.4310.4110.2590.3210.3390.6610.5150.3440.7110.2730.9480.3640.142
Selling & Marketing Expenses 0.0030.0050.0060.0060.0050.0010.0140.0070.0050.0020.0170.0340.1690.0820.0350.0460.0680.0370.013
SG&A 1.8671.8130.7450.0510.5020.5360.4690.8943.1790.2840.4390.7410.7431.2371.3631.1771.7091.7190.458
Other Expenses 0000000.0150.05100000000000
Operating Expenses 7.5584.8242.9834.2962.713.1171.6393.7463.460.2840.4390.7410.8071.9951.951.8491.9962.210.677
Operating Income -13.135-7.089-3.932-4.294-4.727-1.558-1.947-3.824-3.622-0.569-0.701-1.436-1.577-1.958-1.791-1.799-2.092-1.811-0.588
Operating Income Ratio -115.505213.23-2,609.025-1,445.459-1,582.125-3.816-40.782-21.801-117.76-13.874-19.275-134.142-8.57987.506-34.161-37.424-52.011-14.138-6.956
Total Other Income Expenses Net 5.692.7480.0280.04100.0091.1670.016-0.001-0.382-0.062-1.585-0.204-0.096-0.145-0.212-0.156-0.371-0.23
Income Before Tax -7.445-4.34-3.904-4.254-4.727-1.55-1.813-3.808-3.623-0.95-0.763-3.021-1.781-2.055-1.936-1.925-2.107-2.181-0.611
Income Before Tax Ratio -65.466130.56-2,590.671-1,431.674-1,581.983-3.794-37.976-21.711-117.798-23.185-20.978-282.225-9.68991.81-36.922-40.04-52.366-17.032-7.232
Income Tax Expense 00-3.1750-1.1890-1.803-3.827-3.622000.335-0000000
Net Income -7.445-4.34-0.729-4.254-3.538-1.55-1.813-3.808-3.623-0.95-0.763-3.021-1.781-2.055-1.936-1.925-2.107-2.181-0.611
Net Income Ratio -65.466130.56-483.591-1,431.674-1,184.215-3.794-37.976-21.711-117.798-23.185-20.978-282.225-9.68991.81-36.922-40.04-52.366-17.032-7.232
EPS -0.007-0.005-0.001-0.005-0.005-0.002-0.003-0.006-0.007-0.006-0.006-0.024-0.014-0.019-0.021-0.022-0.034-0.06-0.019
EPS Diluted -0.007-0.005-0.001-0.005-0.005-0.002-0.003-0.006-0.007-0.006-0.006-0.024-0.014-0.019-0.021-0.022-0.034-0.06-0.019
EBITDA -7.445-4.498-3.904-4.312-4.726-3.3610-3.8070-0.541-0.668-3.371-1.387-2.076-1.548-1.798-1.954-1.753-0.523
EBITDA Ratio -65.464135.309-2,590.477-1,451.332-1,581.785-8.230-21.7080-13.2-18.352-314.943-7.54692.747-29.534-37.401-48.573-13.687-6.193